Sanofi India primarily deals with the Manufacture and sale of pharmaceutical products.
Financial Results:
The company reported a decline of 2.32% YoY in revenue from operations which stood at INR 671.9 crore in the third quarter of FY23, as compared to INR 687.90 crore in the year-ago quarter. In the period ended December 2022, the company reported net expenses of INR 515.4 crore. This is against INR 572 crore that the company posted in the previous year’s quarter.
In the third quarter of FY23, Sanofi India’s profit increased by 44.80% YoY standing at INR 130.9 crore as against INR 90.4 crore. The earnings per share increased from INR 39.25 (recorded in Q3FY22) to INR 56.84 in Q3FY23.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,